What You Should Know: - Medable Inc., the leading SaaS platform provider for patient-centered clinical trials, today announced a new partnership with Withings Health Solutions, the business-to-business division of Withings, one of the global leaders in at-home connected health - Withings’ devices will seamlessly connect to Medable’s decentralized clinical trial platform, reducing the burden on sponsors and sites while empowering patients to participate in trials from home.
Read More
Medable | Digitally Enabled Clinical Trials | News, Analysis, Insights - HIT Consultant
Medable Launches Decentralized Clinical Trials Partner Network
What You Should Know: - Medable Inc., a Palo Alto, CA-based provider for patient-centered clinical trials, today launched the Medable Partner Network – uniting a diverse ecosystem of technology, service, data, site, and direct-to-patient partners that work together to accelerate deployment of decentralized clinical trials. - The network includes new partnerships with Advanced Clinical, Cognizant, and CVS, and expanded relationships with Datavant, Oracle, Parexel, PPD, part of
Read More
CVS Health Taps Medable to Bring Decentralized Clinical Trials to Pharmacies Nationwide
What You Should Know: - Medable and CVS Health announced a strategic collaboration that will make clinical research more accessible to patients of all demographics. Using Medable’s decentralized trial platform available to CVS Health’s thousands of community MinuteClinics nationwide, most people will be within just five minutes of a decentralized clinical trial research site – finally busting the longstanding barrier to research for millions of Americans - Where applicable, CVS Health will
Read More
Medable Secures $304M at $2.1B Valuation for Decentralized Clinical Trials Platform
What You Should Know: - Decentralized Clinical Trials (DCT) leader Medable, today announced a $304M Series D funding round today – the company’s largest and fourth funding round in 18 months, bringing total capital raised to $521M – and valuation to $2B+. The funding round was co-led by new investors Blackstone Growth and Tiger Global and existing investor GSR Ventures. The round also includes follow-on investment from existing investors Sapphire
Read More
Medable Launches Decentralized Clinical Trials Enablement Program
What You Should Know: - Medable Inc., a software platform for patient-centered drug development, today announced an industry-first digital certification program that provides life sciences companies with specialized tools, knowledge sharing and skills development to rapidly scale their decentralized and hybrid trial strategies. - Hybrid/decentralized clinical trials have unleashed an entirely new patient experience, but this new approach to clinical research will only work if
Read More
Medable, Aural Analytics Partner to Develop Remote Cancer Digital Solutions
What You Should Know: - Medable announced today that it is now partnering with Aural Analytics to test and develop remote digital data tools and harmonization methods designed to assess the wellbeing of patients undergoing cancer treatment. - The addition of Aural Analytics’ speech biomarkers application improves outcomes data with important speech and language-based information about motor, cognitive, and respiratory function furthering the scope of digital measures which can be captured
Read More
Medable Raises $78M to Expand Decentralized Clinical Trials Platform for Patient-Centered Drug Development
What You Should Know: - Medable, Inc., a Palo Alto, CA-based global platform for decentralized clinical trials today announced $78M in new funding to fuel advances in the delivery of digital and decentralized clinical trials, accelerating the industry’s shift to patient-centered drug development. The funding was led by Sapphire Ventures, along with new investor Obvious Ventures and follow-on investment from existing investors GSR Ventures, PPD, Inc., and Streamlined Ventures. - This is
Read More
Medable Raises $91M for Global Decentralized Clinical Trials Platform
What You Should
Know: Medable announced
$91 million in new funding to accelerate the life sciences industry’s shift to
digital and decentralized clinical trials, bringing Medable’s total capital
raised to more than $136M. - Medable has played a pivotal role in enabling clinical trials during the COVID-19 pandemic, facilitating the continuation of existing research via remote care as well as accelerating the development of vaccines and therapeutics for COVID-19. Medable,
Read More
Medable Launches TeleConsent for Clinical Trials to Streamline Approvals During Decentralized Trials
What You Should Know: - Medable launches Teleconsent, part of its Telehealth
family of cloud-based software for decentralized clinical trials. - The application represents the next big step in
enabling fully virtual trials and is key to patient-centric trial design
because it allows patients to handle the lengthy process of consenting – and
re-consenting – to trial participation conveniently from anywhere. Medable Inc.,
a software provider for decentralized clinical trials,
Read More
Medable Lands $25M to Expand Platform for Decentralized Clinical Trials
What You Should Know: - Medable raises $25M in funding to expand global platform for decentralized clinical trials led by GSR Ventures, with additional investment from existing investor PPD, Inc. - Founded in 2015, Medable’s global decentralized trial platform streamlines design, recruitment, retention and data quality, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution. Medable, Inc., a Palo
Alto, CA-based global platform for
Read More
